Corient Private Wealth’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$574K Sell
63,737
-118,997
-65% -$1.88M ﹤0.01% 1956
2025
Q4
$3.33M Buy
182,734
+124,908
+216% +$2.11M ﹤0.01% 1252
2025
Q3
$848K Sell
57,826
-19,590
-25% -$336K ﹤0.01% 1511
2025
Q2
$1.41M Buy
77,416
+41,260
+114% +$841K ﹤0.01% 1198
2025
Q1
$717K Buy
36,156
+564
+2% +$9.75K ﹤0.01% 1429
2024
Q4
$610K Sell
35,592
-1,038
-3% -$19.5K ﹤0.01% 1513
2024
Q3
$732K Buy
36,630
+4,291
+13% +$66.7K ﹤0.01% 1553
2024
Q2
$362K Buy
32,339
+1,540
+5% +$12.9K ﹤0.01% 1808
2024
Q1
$203K Buy
30,799
+13
+0% +$71 ﹤0.01% 2095
2023
Q4
$139K Hold
30,786
﹤0.01% 2120
2023
Q3
$110K Hold
30,786
﹤0.01% 2012
2023
Q2
$114K Buy
30,786
+13,293
+76% +$49.3K ﹤0.01% 1964
2023
Q1
$57.9K Hold
17,493
﹤0.01% 1928
2022
Q4
$67.9K Buy
+17,493
New +$54K ﹤0.01% 1604

Other funds holding ADMA